IL88779A - Method for producing chimeric immunocompromised mammals - Google Patents

Method for producing chimeric immunocompromised mammals

Info

Publication number
IL88779A
IL88779A IL8877988A IL8877988A IL88779A IL 88779 A IL88779 A IL 88779A IL 8877988 A IL8877988 A IL 8877988A IL 8877988 A IL8877988 A IL 8877988A IL 88779 A IL88779 A IL 88779A
Authority
IL
Israel
Prior art keywords
cells
host
human
tissue
organ
Prior art date
Application number
IL8877988A
Other languages
English (en)
Other versions
IL88779A0 (en
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22476130&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL88779(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of IL88779A0 publication Critical patent/IL88779A0/xx
Publication of IL88779A publication Critical patent/IL88779A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Environmental Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • AIDS & HIV (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL8877988A 1987-12-23 1988-12-23 Method for producing chimeric immunocompromised mammals IL88779A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13717387A 1987-12-23 1987-12-23

Publications (2)

Publication Number Publication Date
IL88779A0 IL88779A0 (en) 1989-07-31
IL88779A true IL88779A (en) 1995-07-31

Family

ID=22476130

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8877988A IL88779A (en) 1987-12-23 1988-12-23 Method for producing chimeric immunocompromised mammals

Country Status (8)

Country Link
EP (1) EP0322240B1 (fr)
JP (1) JP2801228B2 (fr)
AT (1) ATE119197T1 (fr)
AU (1) AU2754888A (fr)
DE (1) DE3853201T2 (fr)
DK (1) DK720488A (fr)
ES (1) ES2071620T3 (fr)
IL (1) IL88779A (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
US6713610B1 (en) 1990-01-12 2004-03-30 Raju Kucherlapati Human antibodies derived from immunized xenomice
US6150584A (en) * 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6673986B1 (en) * 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US6075181A (en) * 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1991010741A1 (fr) * 1990-01-12 1991-07-25 Cell Genesys, Inc. Generation d'anticorps xenogeniques
EP0438053B1 (fr) * 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Implantation durable et développement d'une lignée hématopoiétique humaine chez des mammifères normaux
US5849288A (en) * 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5652373A (en) * 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5147784A (en) * 1990-04-12 1992-09-15 Systemix, Inc. T-lymphocyte progenitor cell assay
CA2063408A1 (fr) * 1990-05-03 1991-11-04 Susan Mayo Tissu lymphoide humain d'un hote immunodeprime
WO1991018615A1 (fr) * 1990-05-25 1991-12-12 Systemix, Inc. Globules de sang peripherique humain chez un hote presentant un deficit immunitaire
DK9091D0 (da) * 1991-01-18 1991-01-18 Novo Nordisk As Fremgangsmaade til fremstilling af antistoffer
US5858328A (en) * 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5849987A (en) * 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) * 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
EP0539970B1 (fr) * 1991-10-30 1999-05-26 Idemitsu Kosan Company Limited Procédés de production des lymphocytes humains et des anticorps humains, et anticorps humains ainsi produits
US6353150B1 (en) * 1991-11-22 2002-03-05 Hsc Research And Development Limited Partnership Chimeric mammals with human hematopoietic cells
NL9102122A (nl) * 1991-12-18 1993-07-16 Tno Werkwijze voor het testen van antivirale middelen; daarvoor bruikbare proefdieren.
US5866757A (en) * 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
WO1994016080A1 (fr) * 1993-01-08 1994-07-21 Exemplar Corporation Procede in vitro/in vivo d'identification de medicaments anti-neoplasiques
GB9317766D0 (en) * 1993-08-26 1993-10-13 Agricultural & Food Res Animal models
US5972627A (en) * 1994-06-15 1999-10-26 Systemix, Inc. Method of purifying a population of cells enriched for dendritic and/or lymphoid progenitors and populations of cells obtained thereby
US5985660A (en) * 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
WO1996001120A1 (fr) * 1994-07-03 1996-01-18 P.N. Gerolymatos S.A. Produits thymiques et applications
US6455756B1 (en) * 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
WO1996039811A1 (fr) * 1995-06-07 1996-12-19 Novartis Ag Animaux immunodeprimes a tissu synovial humain
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US5986170A (en) 1995-11-13 1999-11-16 Corixa Corporation Murine model for human carcinoma
EP1500329B1 (fr) 1996-12-03 2012-03-21 Amgen Fremont Inc. Les anticorps humains qui lient en particulier l'alpha de TNF humain
JP2002503091A (ja) 1997-03-26 2002-01-29 リプロジェン，インコーポレイテッド 子宮内膜症マウスモデル
EP0973381B1 (fr) * 1997-04-09 2010-03-03 AMDL, Inc. Model animal aux fins d'une appréciation de vaccins
EP1079688A1 (fr) * 1998-05-26 2001-03-07 Innogenetics N.V. Procede permettant d'augmenter des lymphocytes b de primates chez la souris immunodeprimee, et de produire de grands nombres de lymphocytes b specifiques de l'antigene pour la production d'anticorps monoclonaux de primates
TW200813086A (en) 2006-05-11 2008-03-16 Hoffmann La Roche Immunereconstituted mouse
SG10201403703XA (en) * 2009-06-29 2014-10-30 Qingfeng Chen Methods of producing humanized non-human mammals
US8541646B2 (en) 2009-10-06 2013-09-24 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
KR102109172B1 (ko) 2011-02-15 2020-05-12 리제너론 파마슈티칼스 인코포레이티드 인간화된 ｍ－ｃｓｆ 마우스
IL282472B2 (en) 2012-09-07 2024-04-01 Regeneron Pharma Genetically modified non-human animals and methods of their use
SG10201707449TA (en) 2012-11-05 2017-10-30 Regeneron Pharma Genetically modified non-human animals and methods of use thereof
ES2854276T3 (es) 2014-05-19 2021-09-21 Regeneron Pharma Animales no humanos modificados genéticamente que expresan EPO humana
WO2016168212A1 (fr) 2015-04-13 2016-10-20 Regeneron Pharmaceuticals, Inc. Souris "knockin" sirpa-il15 humanisées et leurs procédés d'utilisation

Also Published As

Publication number Publication date
DK720488D0 (da) 1988-12-23
DE3853201T2 (de) 1995-09-14
ES2071620T3 (es) 1995-07-01
JPH0231632A (ja) 1990-02-01
AU2754888A (en) 1989-06-29
EP0322240A2 (fr) 1989-06-28
ATE119197T1 (de) 1995-03-15
EP0322240B1 (fr) 1995-03-01
DK720488A (da) 1989-06-24
IL88779A0 (en) 1989-07-31
EP0322240A3 (en) 1990-04-18
DE3853201D1 (de) 1995-04-06
JP2801228B2 (ja) 1998-09-21

Similar Documents

Publication Publication Date Title
EP0322240B1 (fr) Mammifères immunocompromis chimériques et leur utilisation
Pearson et al. Creation of “humanized” mice to study human immunity
Ranheim et al. Frizzled 9 knock-out mice have abnormal B-cell development
US20140178408A1 (en) Method of producing an antibody
US5147784A (en) T-lymphocyte progenitor cell assay
EP0469632A1 (fr) Systèmes des organes xénogènes modulés dans un hôte immunocompris
Won et al. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis
US5639939A (en) Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
US5434341A (en) Xenogeneic lymph node in mammary fat pad
JPWO2004110139A1 (ja) ヒト由来免疫担当細胞の製造方法
US6455756B1 (en) Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
Turner et al. In utero transplantation of human fetal haemopoietic cells in NOD/SCID mice
Xiao et al. A non-leaky Artemis-deficient mouse that accurately models the human severe combined immune deficiency phenotype, including resistance to hematopoietic stem cell transplantation
CN1927137A (zh) 抵制抗供体免疫的移植前适应器官
Chambers et al. Exogenous Mtv-7 superantigen transgene expression in major histocompatibility complex class II IE-mice reconstituted with embryonic stem cell-derived hematopoietic stem cells.
US5516977A (en) Xenogeneic tissue implant in ear pinna
US6548737B1 (en) Transgenic mice deficient in natural killer cells
US11419317B2 (en) Non-human animal having human IL-34 and use Thereof
US20200236913A1 (en) A chimeric animal comprising stably transplanted bat cells
Dunn et al. Bone marrow failure in PNH
Lasrado et al. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis
Nauman Humanized Mouse Models for Xenotolerance and Autoimmunity
JP4441680B2 (ja) 造血器腫瘍のアッセイ方法
Guimond Evaluations of functions of uterine natural killer cells during pregnancy in mice
McCarter et al. Studies of Lymphocyte Reconstitution in

Legal Events

Date Code Title Description
CB Opposition filed against grant of patent

Free format text: 18.10.95

CO Opposition cancelled (oppos. filed against grant of patent)

Free format text: OPPOSITION CANCELLED ON 12.8.96

KB Patent renewed
RH Patent void
RH1 Patent not in force